Diagnostic capsule as well as preparation method and application thereof
By designing hollow capsule structure and iron-containing pathfinder capsules, the problem of existing pathfinder capsules not being completely dissolved and difficult to check for intestinal suitability is solved, and a complete dissolution and safe and non-invasive examination method in the human body is achieved. .
Patent Information
- Application Number
- CN202411276790.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-11
- Publication Date
- 2024-12-03
AI Technical Summary
The existing trailer capsules cannot be completely dissolved in the human body, which has a risk of retention, and it is difficult to judge the intestinal suitability examination, so X-ray detection needs to be used to increase radiation damage.
A pathfinding capsule consisting of the first disintegration and the second disintegration of hollow capsule structures is designed. The first disintegration consists of anhydrous lactose, diluent, lubricant, polyvinylpyrrolidone and silica, and the second The disintegrating iron-containing agent is connected by enteric-coated film coating and binder to ensure complete dissolution in the gastrointestinal tract and avoid retention.
The pathfinder capsules are completely dissolved in the human body without risk of retention, and the intestinal patency is judged by the color of the bowel movement, avoiding the use of X-ray detection, and improving safety and inspection efficiency.
Smart Images

Figure FT_1 
Figure FT_2 
Figure SMS_1
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a pathfinder capsule, a preparation method thereof and applications thereof. Background Art
[0002] The full name of capsule endoscopy is "intelligent capsule digestive tract endoscopy system", also known as "medical wireless endoscopy". It is a smart capsule (pathfinder capsule) with a built-in camera and signal transmission device that the examinee orally takes. With the help of digestive tract peristalsis, it moves in the digestive tract and takes images. The doctor uses an external image recorder and imaging workstation to understand the entire digestive tract of the examinee and make a diagnosis of his condition. Since capsule endoscopy has the advantages of convenient examination, no trauma, no wires, no pain, no cross infection, and no impact on the normal work of patients, it expands the field of view of digestive tract examination and overcomes the defects of traditional insertable endoscopes such as poor tolerance and unsuitability for the elderly, the weak and critically ill. Therefore, it has become the preferred method for diagnosing digestive tract diseases, especially small intestinal diseases.
[0003] However, during clinical examinations with capsule endoscopy, doctors found that some patients may have the risk of smart capsules being retained in the body due to intestinal stenosis caused by tumors or various diseases. Normal capsule endoscopes are non-degradable. If a capsule is retained in the body, it must be removed, otherwise serious consequences will occur. Different from the stomach and colon, the small intestine has a special anatomical position, and it is difficult to remove the capsule after it is retained. Sometimes, laparotomy is even required, which brings great pain to patients and even causes medical disputes. Therefore, a method is needed to accurately determine whether the intestinal conditions are suitable for capsule endoscopy. This method is not only non-invasive, safe, and reliable, but also does not subject patients to unnecessary examinations or surgeries, nor does it allow patients to lose the opportunity to use capsule endoscopy to examine diseases.
[0004] The pathfinder capsule of the prior art includes two parts: a capsule body and a radio detector. The capsule body is completely consistent with the shape and size of a gastrointestinal capsule endoscope, and is mainly composed of a degradable lactose material, and contains a barium agent and a wireless radio frequency sensor that can be developed under X-rays, but does not contain the same lens and electronic components as the gastrointestinal capsule endoscope. This pathfinder capsule is provided with time indicators at both ends. When it encounters a narrow part in the body and is retained, the time indicator of the capsule body can be dissolved under the action of digestive fluid, thereby degrading the entire capsule body. However, the above-mentioned pathfinder capsule contains a wireless radio frequency sensor, which is mostly a non-degradable electronic device. After entering the human body, there is still a certain risk of retention. Moreover, if the wireless radio frequency sensor cannot be detected, in most cases, X-rays are required to detect whether the capsule is excreted from the body, which increases the damage of human radiation. Therefore, it is of great significance to provide a pathfinder capsule that can be completely dissolved in the human body without the risk of retention in the body. Summary of the invention
[0005] The technical problem solved by the present invention is to provide a pathfinder capsule. The pathfinder capsule provided by the present application can be completely dissolved in the human body without the risk of being retained in the body.
[0006] In view of this, the present application provides a pathfinder capsule, which comprises a first disintegrating body of a hollow capsule structure, a capsule coating disposed on the surface of the first disintegrating body, and a second disintegrating body filled in the hollow part of the first disintegrating body;
[0007] The thickness of the capsule coating is 0.1-1 mm;
[0008] In terms of mass percentage, the raw materials of the first disintegrating body include: 50-70% anhydrous lactose, 15-35% diluent, 2-10% lubricant, 2-5% polyvinyl pyrrolidone, and 0-5% silicon dioxide; the thickness of the first disintegrating body is 3-5 mm, and the density is 1.1-1.6 g / cm 3 ;
[0009] The second disintegrating body includes an iron agent.
[0010] Preferably, the second disintegrating body is a granular mixture containing an iron agent, and the diameter of the mixture containing an iron agent is 0.2-2 mm.
[0011] Preferably, in terms of mass percentage, the second disintegrating body comprises: 10-30% iron agent, 40-70% starch, 0-20% glucose, 5-10% magnesium stearate, and 0-5% silicon dioxide; the iron agent is selected from one of ferrous fumarate, ferrous gluconate, ferrous sulfate and ferrous lactate.
[0012] Preferably, the first disintegrating body is composed of two hollow half capsules, which are connected by an adhesive; and the capsule coating is an enteric film coating.
[0013] The present application also provides a method for preparing the pathfinder capsule, comprising the following steps:
[0014] S1) Mix anhydrous lactose, diluent, lubricant, polyvinyl pyrrolidone and silicon dioxide according to the mass ratio and press to a density of 1.1~1.6g / cm 3 Then a first disintegrated body is obtained, wherein the thickness of the first disintegrated body is 3-5 mm;
[0015] S2) filling a second disintegrating body into the hollow part of the first disintegrating body;
[0016] S3) coating the surface of the first disintegrating body with a capsule coating having a thickness of 0.1-1 mm to obtain a pathfinder capsule.
[0017] Preferably, step S1) and step S2) are specifically as follows:
[0018] Anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide are mixed according to a mass ratio and put into a first hollow half-capsule-shaped mold of a tablet press, and pressed to obtain a first hollow half-capsule of a first disintegrating body;
[0019] Anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide are mixed in the same mass ratio and put into a second hollow half-capsule-shaped mold of a tablet press, and compressed to obtain a second hollow half-capsule of the first disintegrating body;
[0020] The granules of the second disintegrating body are placed in the hollow part of the first disintegrating body, and then the first hollow half capsule and the second hollow half capsule are connected by a binder.
[0021] Preferably, the pressing pressure is 0.5-1.5T, and the pressing time is 1-10min.
[0022] The present application also provides the use of a pathfinder capsule in determining intestinal obstruction conditions, wherein the pathfinder capsule is the pathfinder capsule described above or the pathfinder capsule prepared by the preparation method described above.
[0023] Preferably, the application is specifically:
[0024] Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours;
[0025] If so, capsule endoscopy is appropriate;
[0026] If not, capsule endoscopy is not appropriate.
[0027] Preferably, the application is specifically:
[0028] Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours;
[0029] If so, capsule endoscopy is appropriate;
[0030] If not, observe the discharge of black stool for >30h, then capsule endoscopy is not suitable.
[0031] The present application provides a pathfinder capsule, which comprises a first disintegrating body of a hollow capsule structure, a capsule coating arranged on the surface of the first disintegrating body, and a second disintegrating body filled in the hollow part of the first disintegrating body, wherein the thickness of the capsule coating is 0.1-1 mm, the raw materials of the first disintegrating body include anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide in a specific proportion, and the thickness of the first disintegrating body is 3-5 mm, and the density is 1.1-1.6 g / cm 3; In the pathfinder capsule provided in the present application, the capsule coating of a specific material makes it insoluble in the stomach, but dissolves within 2 hours after entering the small intestine; the raw material composition, thickness and density of the first disintegrating body are limited, so that the first disintegrating body partially dissolves within 30 hours (<30 hours), but still maintains a complete capsule shape, and the second disintegrating body does not leak in the first disintegrating body, and within 30 to 72 hours after the pathfinder capsule enters the small intestine, the first disintegrating body completely disintegrates, and the second disintegrating body is exposed to the digestive fluid. At the same time, the second disintegrating body will disperse in the digestive tract after contacting the digestive fluid, thereby realizing the dissolution of the pathfinder capsule in the human body, and there is no retention in the body.
[0032] Furthermore, the addition of iron in the second disintegrating body of the present application causes a portion of the iron to be absorbed by the human body in the digestive tract, while the unabsorbed portion combines with hydrogen sulfide in the intestine to form black iron sulfide, which is excreted from the body with feces. In this way, the patient's black stool can be observed without the need for X-ray or CT examinations, and it is harmless to the human body. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 Schematic diagram of the structure of the pathfinder capsule of the present invention; wherein 1 is the capsule coating, 2 is the first disintegrating body, 3 is the second disintegrating body, 2-1 is the first hollow half capsule of the first disintegrating body, and 2-2 is the second hollow half capsule of the first disintegrating body;
[0034] Figure 2 The figure is a schematic diagram of the specific application of the pathfinder capsule of the present invention. DETAILED DESCRIPTION
[0035] In order to further understand the present invention, preferred embodiments of the present invention are described below in conjunction with examples. However, it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention, rather than limiting the claims of the present invention.
[0036] In view of the problem of pathfinder capsules being retained in the human body in the prior art, the present application provides a pathfinder capsule, which introduces a capsule coating, a first disintegrating body and a second disintegrating body, and specifically limits them, so that the pathfinder capsule can be discharged within 30 hours when the gastrointestinal tract is unobstructed, and disintegrates within 30 to 73 hours when the gastrointestinal tract is not smooth. While realizing the judgment of whether the gastrointestinal tract is suitable for capsule endoscopy, it can also be completely dissolved in the human body without the risk of being retained in the body; specifically, the embodiment of the present invention discloses a pathfinder capsule, which comprises a first disintegrating body with a hollow capsule structure, a capsule coating arranged on the surface of the first disintegrating body and a second disintegrating body filled in the hollow part of the first disintegrating body;
[0037] The thickness of the capsule coating is 0.1-1 mm;
[0038] In terms of mass percentage, the raw materials of the first disintegrating body include: 50-70% anhydrous lactose, 15-35% diluent, 2-10% lubricant, 2-5% polyvinyl pyrrolidone, and 0-5% silicon dioxide; the thickness of the first disintegrating body is 3-5 mm, and the density is 1.1-1.6 g / cm 3 ;
[0039] The second disintegrating body includes an iron agent.
[0040] The schematic diagram of the structure of the pathfinder capsule provided in this application is as follows Figure 1 As shown, it is composed of a capsule coating 1, a first disintegrating body 2 and a second disintegrating body 3, wherein the capsule coating is an intestinal film coating, which wraps the capsule body - the first disintegrating body 2 and the second disintegrating body 3; the thickness of the capsule coating is 0.1~1mm, specifically, the thickness of the capsule coating is 0.5~0.8mm; for example, the thickness of the capsule coating in the present application is 0.2mm, 0.3mm, 0.4mm, 0.6mm, 0.7mm, 0.8mm, 0.9mm. The capsule coating in the pathfinder capsule is in direct contact with the digestive fluid, so the pathfinder capsule first starts to disintegrate from the capsule coating, and the first disintegrating body starts to disintegrate after the capsule coating disintegrates and ruptures, and the second disintegrating body starts to disintegrate after the first disintegrating body ruptures; thus, the material and thickness of the capsule coating will affect the disintegration time and determine when the first disintegrating body starts to disintegrate. Obviously, the thicker the capsule coating, the longer the disintegration time. The present application limits the material of the capsule coating so that the capsule coating does not dissolve in the stomach and enters the small intestine intact, after which the capsule coating begins to dissolve; and limits the thickness of the capsule coating so that the dissolution time of the capsule coating is expected to be within 2 hours.
[0041] The capsule body consists of two parts - a first disintegrating body 2 and a second disintegrating body 3. The first disintegrating body 2 is in the shape of a hollow capsule, preferably consisting of two hollow half capsules, namely, a first hollow half capsule 2-1 of the first disintegrating body and a second hollow half capsule 2-2 of the first disintegrating body; the two hollow half capsules of the first disintegrating body can be completely the same (the cylindrical parts of the two hollow half capsules are equal) or different (the cylindrical part of one hollow half capsule is longer than the cylindrical part of the other hollow half capsule), but it is necessary to ensure that they are assembled into a complete hollow capsule.
[0042] In the present application, the raw materials of the first disintegrating body include: 50-70% anhydrous lactose, 15-35% diluent, 2-10% lubricant, 2-5% polyvinyl pyrrolidone, and 0-5% silicon dioxide.
[0043] Among them, the diluent is preferably microcrystalline cellulose, which, as a diluent of anhydrous lactose, can dilute the content of anhydrous lactose, reduce the lactose content of the capsule, and reduce the occurrence of lactose intolerance in patients after taking the capsule. Specifically, the content of the diluent is 18-33%; for example, the content of the diluent in this application is 16%, 17%, 19%, 20%, 21%, 22%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 34%.
[0044] The anhydrous lactose is used as the main filler, and its content is specifically 55-63%; for example, in the present application, the content of the anhydrous lactose is 51%, 52%, 53%, 54%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 64%, 65%, 66%, 67%, 68%, and 69%.
[0045] The lubricant is preferably glyceryl behenate, which makes the first disintegrating body easier to form and demold during compression. Specifically, the content of the lubricant is 5-8%; for example, the content of the lubricant in this application is 3%, 4%, 6%, 7%, and 9%.
[0046] The polyvinyl pyrrolidone is used as a disintegrant to promote the disintegration of the first disintegrating body; for example, the content of the polyvinyl pyrrolidone is 3% or 4%. In order to ensure that the pathfinder capsule completely disintegrates after 30 hours, the content of the polyvinyl pyrrolidone should not be too high.
[0047] The silicon dioxide can further improve the compactability of the pathfinder capsule direct tableting and promote the forming of the first disintegrating body; for example, the content of the silicon dioxide is 1wt%, 2wt%, 3wt%, and 4wt%.
[0048] The thickness of the first disintegrating body is 3-5 mm. For example, the thickness of the first disintegrating body is 3 mm, 4 mm or 5 mm. The thicker the first disintegrating body is, the longer the disintegration time is. The above thickness is to ensure that the first disintegrating body of the pathfinder capsule partially disintegrates within 30 hours and the second disintegrating body does not leak. The density of the first disintegrating body is 1.1-1.6 g / cm 3 , for example, the density of the first disintegrated body is 1.2 g / cm 3 , 1.3g / cm 3 , 1.4g / cm 3 or 1.5g / cm 3 If the density of the first disintegrating body is too small, the compactability is insufficient, it is difficult to form, and it is easy to disperse and break. If the density is too large, it is too compact and difficult to complete disintegration within the expected time.
[0049] The second disintegrating body is a granular material, and its diameter ranges from 0.2 to 2 mm. Specifically, the diameter of the granular material of the second disintegrating body is 0.5 to 1.6 mm. For example, the diameter of the granular material described in the present application is 0.3 mm, 0.4 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1.0 mm, 1.1 mm, 1.2 mm, 1.3 mm, 1.4 mm, 1.5 mm, 1.7 mm, 1.8 mm, and 1.9 mm. The smaller the diameter of the granular material of the second disintegrating body, the larger the area in contact with the digestive fluid, and the faster the disintegration speed, and vice versa. However, the diameter of the granular material of the second disintegrating body should not be too small. If it is too small, such as powder, it will affect the fluidity of the digestive fluid and increase the disintegration time.
[0050] In terms of mass percentage, the second disintegration body includes: 10-30% iron agent, 40-70% starch, 0-20% glucose, 5-10% magnesium stearate, and 0-5% silicon dioxide; the iron agent is selected from one of ferrous fumarate, ferrous gluconate, ferrous sulfate, and ferrous lactate. The iron agent can combine with hydrogen sulfide in the intestine to form a black substance that is excreted from the body with stool, and the discharge of the pathfinder capsule can be directly observed; the content of the iron agent is specifically 12-20%; for example, the content of the iron agent described in this application is 11%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29% or 30%.
[0051] The starch is the main component of the second disintegrator, and specifically, its content is 43-60%; for example, the content of starch described in the present application is 41%, 42%, 44%, 45%, 47%, 49%, 50%, 51%, 52%, 54%, 57%, 59%, 61%, 62%, 64%, 66%, 67%, 68%, and 69%.
[0052] The glucose can be rapidly absorbed in the intestine and can promote the disintegration rate of the second disintegrating body in the digestive juice to a certain extent; specifically, the content of glucose is 5-10%; by way of example, the content of glucose described in the present application is 1%, 2%, 3%, 4%, 6%, 7%, 8%, 9%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, and 19%.
[0053] The magnesium stearate is used as a lubricant to improve the granulation property of the second disintegrating body; specifically, the content of the magnesium stearate is 6-8%; for example, the content of the magnesium stearate in the present application is 7% and 9%.
[0054] The silicon dioxide promotes the formation of the second disintegrated body; specifically, the content of the silicon dioxide is 2-4%; for example, the content of the silicon dioxide in the present application is 1% or 3%.
[0055] Furthermore, the present application also provides a method for preparing a pathfinder capsule, comprising the following steps:
[0056] S1) Mix anhydrous lactose, diluent, lubricant, polyvinyl pyrrolidone and silicon dioxide according to the mass ratio and press to a density of 1.1~1.6g / cm 3 Then a first disintegrated body is obtained, wherein the thickness of the first disintegrated body is 3-5 mm;
[0057] S2) filling a second disintegrating body into the hollow part of the first disintegrating body;
[0058] S3) coating the surface of the first disintegrating body with a capsule coating having a thickness of 0.1-1 mm to obtain a pathfinder capsule.
[0059] In the preparation process of the pathfinder capsule, the first disintegrating body is first prepared, that is, anhydrous lactose, a diluent, a lubricant, and polyvinyl pyrrolidone are mixed according to a mass ratio, and the obtained mixture is pressed in a mold to obtain the first disintegrating body; the mold is to achieve the thickness requirement of the first disintegrating body, and the pressing is to achieve the density of the first disintegrating body of 1.1-1.6 g / cm 3 Specifically, the pressing pressure is 0.5~1.5T, and the pressing time is 1~10min.
[0060] After obtaining the first disintegrating body, the second disintegrating body is filled into the hollow part of the first disintegrating body; the filling method is carried out in a manner well known to those skilled in the art, and there is no particular limitation in the present application.
[0061] As a preferred embodiment, the first disintegrating body is composed of a first hollow half capsule and a second hollow half capsule. During the preparation process, the first hollow half capsule and the second hollow half capsule are prepared separately. The above steps are specifically as follows:
[0062] Anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide are mixed according to a mass ratio and put into a first hollow half-capsule-shaped mold of a tablet press, and pressed to obtain a first hollow half-capsule of a first disintegrating body;
[0063] Anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide are mixed in the same mass ratio and put into a second hollow half-capsule-shaped mold of a tablet press, and compressed to obtain a second hollow half-capsule of the first disintegrating body;
[0064] The particles of the second disintegrating body are placed into the hollow part of the first disintegrating body, and then the first hollow half capsule and the second hollow half capsule are connected by a binder.
[0065] In the above preparation process, the ratio of raw materials for preparing the first hollow half capsule and the second hollow half capsule is the same, the first hollow half capsule-shaped mold and the second hollow half capsule-shaped mold are respectively used to determine the shapes of the first hollow half capsule and the second hollow half capsule, and the pressing tool used for pressing is used to determine the size of the first disintegrated body. The above mold and the above pressing tool are devices used by technicians in the preparation process, and this application does not impose any special restrictions on this.
[0066] After obtaining the first hollow half capsule and the second hollow half capsule respectively, the second disintegrating body is first filled into the hollow part of the first disintegrating body composed of the first hollow half capsule and the second hollow half capsule, and then the first hollow half capsule and the second hollow half capsule are connected by a binder; the binder is well known to those skilled in the art and is not particularly limited in this application.
[0067] In the present application, a film coating is finally coated on the surface of the first disintegrating body, namely, a capsule coating, to obtain a final pathfinder capsule.
[0068] After the above-mentioned pathfinder capsule of the present application is swallowed into the body, the capsule coating first contacts with the digestive juice, and the coating does not dissolve in the stomach. The pathfinder capsule will enter the small intestine intact. After the pathfinder capsule enters the small intestine, the capsule coating begins to dissolve, and the expected dissolution time is within 2 hours; after the capsule coating dissolves, the first disintegrating body is exposed to the digestive juice, and the first disintegrating body begins to disintegrate. The first disintegrating body partially dissolves within 30 hours (<30 hours) of contact with the digestive juice, but can still maintain a complete capsule shape, and does not allow the second disintegrating body to leak into the digestive juice; within 30h~72h after the pathfinder capsule enters the small intestine, the first disintegrating body completely disintegrates, and the second disintegrating body is exposed to the digestive juice. Since the second disintegrating body is a granular matter, it will be quickly dispersed in the digestive tract after contacting the digestive juice. A part of it will be absorbed by the human body, and the other part that has not been absorbed in time will combine with hydrogen sulfide in the intestine to form a black substance of iron sulfide, which will be excreted from the body with the feces. At this time, the patient can be observed to have black stools.
[0069] Furthermore, the present application also provides the use of a pathfinder capsule in determining intestinal obstruction; the above-mentioned pathfinder capsule is specifically the pathfinder capsule described in the above-mentioned scheme.
[0070] Specifically, administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours;
[0071] If so, capsule endoscopy is appropriate;
[0072] If not, capsule endoscopy is not appropriate.
[0073] More specifically, a pathfinder capsule is administered, and whether the pathfinder capsule is completely discharged is observed within 30 hours;
[0074] If so, capsule endoscopy is appropriate;
[0075] If not, observe the discharge of black stool for >30h, then capsule endoscopy is not suitable.
[0076] The inspection process diagram of the above-mentioned pathfinder capsule is as follows: Figure 2 As shown in the figure, when the patient's gastrointestinal tract is unobstructed, the pathfinder capsule will be excreted from the body within 30 hours. At this time, the capsule is still in the shape of a capsule, the first disintegrating body is partially disintegrated, and the second disintegrating body is intact. Therefore, if the patient checks the defecation and finds that the pathfinder capsule is excreted from the body, and the stool color is normal, it means that the patient's gastrointestinal tract is unobstructed and capsule endoscopy can be performed; when the patient has intestinal obstruction and stenosis, the pathfinder capsule will be stuck in the intestine. At this time, the retention time of the capsule in the patient's body will exceed 30 hours. If the patient checks the defecation situation between 30 and 72 hours, it will be found that there is black stool, which means that the patient is not suitable for capsule endoscopy. Therefore, according to the above method, the pathfinder capsule can be judged whether it is excreted from the body by the stool color without the need for X-ray or CT examination, which is harmless to the human body.
[0077] The pathfinder capsule provided in the present application can be completely dissolved in the human body without the risk of retention in the body. Furthermore, the pathfinder capsule provided in the present application can be judged whether it has been excreted by observing the color of the stool. There is no need for X-ray or CT examination, and it is harmless to the human body. In addition, the pathfinder capsule provided in the present application has a simple structure, is easy to produce and process, and can improve production efficiency.
[0078] In order to further understand the present invention, the pathfinder capsule provided by the present invention, its preparation method and application are described in detail below in conjunction with embodiments. The protection scope of the present invention is not limited by the following embodiments.
[0079] Example 1
[0080] (1) Weigh 2.37 g of anhydrous lactose, microcrystalline cellulose, glyceryl behenate, polyvinyl pyrrolidone, and silicon dioxide in a mass ratio of 60:25:8:5:2, mix them evenly, and put them into the first hollow semi-capsule-shaped mold of a tablet press. Use a press with a controlled capsule thickness of 4 mm and a hollow diameter of 4 mm. Under a pressure of 1 T, maintain the pressure for 2 minutes, open the mold, and obtain the first part of the hollow capsule-shaped first disintegrated body with a density of 1.3 g / cm 3 ;
[0081] (2) Weigh 0.59 g of anhydrous lactose, microcrystalline cellulose, glyceryl behenate, polyvinyl pyrrolidone, and silicon dioxide in a mass ratio of 60:25:8:5:2, mix them evenly, and put them into the second hollow semi-capsule-shaped mold of the tablet press. Use a press with a controlled capsule thickness of 4 mm and a hollow diameter of 4 mm. Under a pressure of 1 T, maintain the pressure for 2 minutes, open the mold, and obtain the second part of the first disintegrated body in the hollow capsule shape. The density is 1.3 g / cm 3 ;
[0082] (3) Weighing 0.3 g of iron, starch, glucose, magnesium stearate, and silicon dioxide in a mass ratio of 20:60:10:8:2, mixing them evenly and placing them in a granulator to prepare a second disintegrating body granule with a diameter of 1 mm;
[0083] (4) placing the second disintegrating body granules into the hollow part of the first disintegrating body to obtain a solid capsule body;
[0084] (5) Prepare a 6 wt% adhesive liquid, apply a layer evenly on the edge of the first disintegrating body connection to form an adhesive layer, connect the first disintegrating bodies at both ends and dry them;
[0085] (6) The assembled solid capsule body is placed into a coating machine and coated with a 0.5 mm thick capsule coating to obtain a complete pathfinder capsule.
[0086] Example 2
[0087] The preparation method is the same as that of Example 1, except that the total mass weighed in step (1) is 2.0 g, the total mass weighed in step (2) is 0.5 g, and the density of the first disintegrated body is 1.1 g / cm 3 ;
[0088] Example 3
[0089] The preparation method is the same as that of Example 1, except that the total mass weighed in step (1) is 2.92 g, the total mass weighed in step (2) is 0.73 g, and the density of the first disintegrated body is 1.6 g / cm 3 ;
[0090] Example 4
[0091] The preparation method is the same as that of Example 1, except that the mass ratio of anhydrous lactose, microcrystalline cellulose, glyceryl behenate, polyvinyl pyrrolidone and silicon dioxide in step (1) and step (2) is 70:15:5:5:5.
[0092] Example 5
[0093] The preparation method is the same as that of Example 1, except that: in step (1) and step (2), a press having a capsule thickness of 3 mm and a hollow diameter of 4 mm is used; in order to keep the density of the first disintegrated body unchanged, the total mass weighed in step (1) is 1.61 g, and the total mass weighed in step (2) is 0.4 g.
[0094] Example 6
[0095] The preparation method is the same as that of Example 1, except that: in step (1) and step (2), a press having a capsule thickness of 5 mm and a hollow diameter of 4 mm is used; in order to keep the density of the first disintegrated body unchanged, the total mass weighed in step (1) is 3.28 g, and the total mass weighed in step (2) is 0.82 g.
[0096] Example 7
[0097] The preparation method is the same as that of Example 1, except that the thickness of the capsule coating in step (6) is 0.1 mm.
[0098] Example 8
[0099] The preparation method is the same as that of Example 1, except that the thickness of the capsule coating in step (6) is 1 mm.
[0100] Comparative Example 1
[0101] The preparation method is the same as that of Example 1, except that the total mass weighed in step (1) is 1.82 g, the total mass weighed in step (2) is 0.46 g, and the density of the first disintegrated body is 1.0 g / cm 3 .
[0102] Comparative Example 2
[0103] The preparation method is the same as that of Example 1, except that the total mass weighed in step (1) is 3.09 g, the total mass weighed in step (2) is 0.77 g, and the density of the first disintegrated body is 1.7 g / cm 3 .
[0104] Comparative Example 3
[0105] The preparation method is the same as that of Example 1, except that the mass ratio of anhydrous lactose, microcrystalline cellulose, glyceryl behenate, polyvinyl pyrrolidone and silicon dioxide in step (1) and step (2) is 70:10:5:15:0.
[0106] Comparative Example 4
[0107] The preparation method is the same as that of Example 1, except that: in step (1) and step (2), a press having a capsule thickness of 2 mm and a hollow diameter of 4 mm is used; in order to keep the density of the first disintegrated body unchanged, the total mass weighed in step (1) is 1.48 g, and the total mass weighed in step (2) is 0.49 g.
[0108] Comparative Example 5
[0109] The preparation method is the same as that of Example 1, except that: in step (1) and step (2), a press having a capsule thickness of 6 mm and a hollow diameter of 4 mm is used; in order to keep the density of the first disintegrated body unchanged, the total mass weighed in step (1) is 7.42 g, and the total mass weighed in step (2) is 2.47 g.
[0110] Comparative Example 6
[0111] The preparation method is the same as that of Example 1, except that the thickness of the capsule coating in step (3) is 0.05 mm.
[0112] Comparative Example 7
[0113] The preparation method is the same as that in Example 1, except that the thickness of the capsule coating in step (3) is 5 mm.
[0114] The disintegration time of the Pathfinder capsules prepared in Examples 1 to 8 and Comparative Examples 1 to 7 was tested according to the following method:
[0115] Prepare artificial gastric juice: take 16.4 mL of dilute hydrochloric acid, add 800 mL of water and 10 g of pepsin and dilute to 1000 mL; dilute hydrochloric acid is 234 mL of concentrated hydrochloric acid diluted to 1000 mL with water to obtain 9.5%~10.5% dilute hydrochloric acid;
[0116] Prepare artificial intestinal fluid: take 6.8g of potassium dihydrogen phosphate, add 500ml of water to dissolve it, and adjust the pH to 6.8 with 0.4% sodium hydroxide solution; take 10g of pancreatic enzyme (meeting the requirements of the pharmacopoeia), add appropriate amount of water to dissolve it; mix the two liquids, and dilute with water to 1000ml to obtain artificial intestinal fluid;
[0117] 500 ml of artificial gastric juice and artificial intestinal juice were put into the beaker of the disintegration instrument. The up and down swing of the disintegration instrument was used to replace gastrointestinal peristalsis. After the pathfinder capsule was swung in the artificial gastric juice for 2 hours, it was taken out and put into the artificial intestinal juice. The swing was continued, the disintegration of the capsule was observed, and the disintegration time was recorded. The results are shown in Table 1:
[0118] Table 1 Disintegration time data of the Pathfinder capsules prepared in Examples 1 to 10
[0119]
[0120] Example 11 Animal experiment using experimental pigs
[0121] Before the experiment, the experimental animals were prepared for intestinal tract according to the method of capsule endoscopy: one end of the pathfinder capsule to be tested was fixed with a traction rope, and the fixed position was the non-isolation zone part of the outer surface of the pathfinder capsule coating, which was used to prevent the pathfinder capsule from being discharged from the experimental animal in advance; during the experiment, the pathfinder capsule was sent into the duodenum of the experimental animal by an electronic gastroscope, and the length of the traction rope was fixed so that the pathfinder capsule was always in the intestine of the experimental animal in a complete state; after the pathfinder capsule was sent into the body of the experimental animal, the stool color of the experimental animal was recorded within 30 hours (<30h) and 30-72 hours after the capsule was sent in, so as to obtain the disintegration of the pathfinder capsule in the experimental animal. The results of the animal experiment are shown in Table 2;
[0122] Table 2 Animal experiment results data table
[0123]
[0124] As can be seen from the above table, according to the test results of Example 1 and Comparative Example 3, the disintegration time can be adjusted by changing the composition ratio of the first disintegrating body; according to the test results of Examples 1 to 3 and Comparative Examples 1 to 2, the disintegration time can be adjusted by adjusting the density of the first disintegrating body; according to the test results of Examples 5 to 6 and Comparative Examples 4 to 5, the disintegration time can be adjusted by changing the thickness of the first disintegrating body; according to the test results of Examples 7 to 8 and Comparative Examples 6 to 7, the capsule disintegration time can be prolonged by increasing the thickness of the capsule coating.
[0125] In Comparative Examples 1, 3, 4 and 6, the pathfinder capsules had black stool within 30 hours, indicating that the disintegration time of the pathfinder capsules was less than 30 hours, and they did not disintegrate within the expected range of 30 to 72 hours. At this time, the pathfinder capsules could no longer determine whether the user was suitable for capsule endoscopy, and misjudgment might occur; the pathfinder capsules in Comparative Examples 2, 5 and 7 had a disintegration time of more than 72 hours. Although it could be determined that the user was not suitable for capsule endoscopy, the pathfinder capsules were retained in the body due to the failure to disintegrate in time, and the original intention of designing the pathfinder capsules was to prevent capsule retention. Therefore, it is necessary to control the density, thickness, material ratio and capsule coating thickness of the first disintegrating body of the pathfinder capsules to appropriate values so that the disintegration time of the pathfinder capsules is controlled within 30 to 72 hours.
[0126] The above embodiments are only used to help understand the method and core idea of the present invention. It should be noted that, for those skilled in the art, several improvements and modifications can be made to the present invention without departing from the principles of the present invention, and these improvements and modifications also fall within the scope of protection of the claims of the present invention.
[0127] The above description of the disclosed embodiments enables one skilled in the art to implement or use the present invention. Various modifications to these embodiments will be apparent to one skilled in the art, and the general principles defined herein may be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to the embodiments shown herein, but rather to the widest scope consistent with the principles and novel features disclosed herein.
Claims
1. A pathfinder capsule, comprising a first disintegrating body of a hollow capsule structure, a capsule coating disposed on the surface of the first disintegrating body, and a second disintegrating body filled in the hollow part of the first disintegrating body; The thickness of the capsule coating is 0.1-1 mm; In terms of mass percentage, the raw materials of the first disintegrating body include: 50-70% anhydrous lactose, 15-35% diluent, 2-10% lubricant, 2-5% polyvinyl pyrrolidone, and 0-5% silicon dioxide; the thickness of the first disintegrating body is 3-5 mm, and the density is 1.1-1.6 g / cm 3 ; The second disintegrating body includes an iron agent.
2. The pathfinder capsule according to claim 1, characterized in that: The second disintegrating body is a granular mixture containing an iron agent, and the diameter of the mixture containing an iron agent is 0.2 to 2 mm.
3. The pathfinder capsule according to claim 1, characterized in that: In terms of mass percentage, the second disintegrating body includes: 10-30% iron agent, 40-70% starch, 0-20% glucose, 5-10% magnesium stearate, and 0-5% silicon dioxide; the iron agent is selected from one of ferrous fumarate, ferrous gluconate, ferrous sulfate, and ferrous lactate.
4. The pathfinder capsule according to claim 1, characterized in that: The first disintegrating body is composed of two hollow half capsules which are connected by an adhesive; and the capsule coating is an enteric film coating.
5. The method for preparing the pathfinder capsule according to claim 1 comprises the following steps: S1) Mix anhydrous lactose, diluent, lubricant, polyvinyl pyrrolidone and silicon dioxide according to the mass ratio and press to a density of 1.1~1.6g / cm 3 Then a first disintegrated body is obtained, wherein the thickness of the first disintegrated body is 3-5 mm; S2) filling a second disintegrating body into the hollow part of the first disintegrating body; S3) coating the surface of the first disintegrating body with a capsule coating having a thickness of 0.1-1 mm to obtain a pathfinder capsule.
6. The preparation method according to claim 5, characterized in that: Step S1) and step S2) are specifically as follows: Anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide are mixed according to a mass ratio and put into a first hollow half-capsule-shaped mold of a tablet press, and compressed to obtain a first hollow half-capsule of a first disintegrating body; Anhydrous lactose, a diluent, a lubricant, polyvinyl pyrrolidone and silicon dioxide are mixed in the same mass ratio and put into a second hollow half-capsule-shaped mold of a tablet press, and compressed to obtain a second hollow half-capsule of the first disintegrating body; The granules of the second disintegrating body are placed in the hollow part of the first disintegrating body, and then the first hollow half capsule and the second hollow half capsule are connected by a binder.
7. The preparation method according to claim 5 or 6, characterized in that: The pressing pressure is 0.5-1.5T, and the pressing time is 1-10min.
8. Use of a pathfinder capsule in determining intestinal obstruction, wherein the pathfinder capsule is the pathfinder capsule described in any one of claims 1 to 4 or the pathfinder capsule prepared by the preparation method described in any one of claims 5 to 7.
9. The use according to claim 8, characterized in that: The application is specifically: Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours; If so, capsule endoscopy is appropriate; If not, capsule endoscopy is not appropriate.
10. The use according to claim 8, characterized in that: The application is specifically: Administer the pathfinder capsule and observe whether the pathfinder capsule is completely discharged within 30 hours; If so, capsule endoscopy is appropriate; If not, observe the discharge of black stool for >30h, then capsule endoscopy is not suitable.
